Valuation Acarix AB Deutsche Boerse AG
Stocks
7AC
SE0009268717
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0152 EUR | 0.00% |
|
-8.43% | -11.63% |
| 06-17 | Acarix AB Announces Directorate Appointments | CI |
| 06-16 | Acarix AB Announces That Marlou Janssen-Counott Declines Re-Election as A Member of the Board of Directors | CI |
Company Valuation: Acarix AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 219.7 | 71.81 | 139.9 | 267 | 332.5 | 295.7 | - | - |
| Change | - | -67.32% | 94.84% | 90.83% | 24.52% | -11.06% | - | - |
| Enterprise Value (EV) | 203.9 | 60.65 | 139.9 | 267 | 332.5 | 295.7 | 295.7 | 295.7 |
| Change | - | -70.25% | 130.69% | 90.83% | 24.52% | -11.06% | 0% | 0% |
| P/E | -2.36x | - | -1.19x | -3.59x | - | - | - | - |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | - | - | 0.1x | - | - | - | - |
| Capitalization / Revenue | 58.4x | 12.3x | 22.4x | 43.1x | 45.2x | 15.5x | 4.25x | 2.04x |
| EV / Revenue | 0x | 0x | 0x | 0x | 0x | 15.5x | 4.25x | 2.04x |
| EV / EBITDA | -0x | -0x | -0x | -0x | -0x | -11.6x | 41.1x | 4.63x |
| EV / EBIT | -0x | -0x | -0x | -0x | -0x | -10.3x | 123x | 5.36x |
| EV / FCF | - | - | - | - | - | - | - | - |
| FCF Yield | - | - | - | - | - | - | - | - |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.37 | - | -0.16 | -0.07 | - | - | - | - |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 3.76 | 5.822 | 6.241 | 6.202 | 7.361 | 19.1 | 69.5 | 145.2 |
| EBITDA 1 | -48.32 | -73.44 | -74.46 | -63.08 | -44.54 | -25.6 | 7.2 | 63.9 |
| EBIT 1 | -51.7 | -76.48 | -77.55 | -66.37 | -48.01 | -28.6 | 2.4 | 55.2 |
| Net income 1 | -51.73 | -76.98 | -77.84 | -66.19 | -40.84 | -28.9 | 2.4 | 55.2 |
| Net Debt | -15.86 | -11.16 | - | - | - | - | - | - |
| Reference price 2 | 0.8720 | 0.2850 | 0.1898 | 0.2510 | 0.2680 | 0.2490 | 0.2490 | 0.2490 |
| Nbr of stocks (in thousands) | 251,972 | 251,972 | 737,189 | 1,063,744 | 1,240,557 | 1,187,498 | - | - |
| Announcement Date | 2/17/22 | 2/16/23 | 2/15/24 | 2/13/25 | 2/12/26 | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 55.92x | 4.59x | 15.32x | 0.39% | 15.63B | |
| 36.59x | - | - | 2.21% | 1.57B | |
| 18.56x | 2.67x | 8.97x | 2.12% | 1.12B | |
| -8.54x | 1.19x | 5.22x | -.--% | 932M | |
| 54.21x | - | - | 0.83% | 554M | |
| 45.29x | - | - | - | 444M | |
| 18.55x | 2.61x | 11.17x | 1.84% | 382M | |
| 22.49x | 3.95x | 13.3x | 2.01% | 341M | |
| Average | 30.38x | 3.00x | 10.80x | 1.34% | 2.62B | |
| Weighted average by Cap. | 48.12x | 4.25x | 14.30x | 0.67% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- ACARIX Stock
- 7AC Stock
- Valuation Acarix AB
Select your edition
All financial news and data tailored to specific country editions
